Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis
Systematic review / meta-analysis
OA: green
CC0
AI-generated summary
This systematic review and meta-analysis evaluated the impact of dienogest pretreatment on IVF-ET outcomes, specifically performing a sensitivity analysis for the miscarriage rate.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Additional file 9: Figure S9. Sensitivity analysis for miscarriage rate in the DNG group versus non-DNG group. DNG, dienogest; CI, confidence interval.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (42)
- A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis via openalex
- Dienogest: a new therapeutic agent for the treatment of endometriosis via openalex
- Dienogest: a review of its use in the treatment of endometriosis via openalex
- Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis via openalex
- Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest in the treatment of endometriosis via openalex
- Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration via openalex
- Endometriosis: current therapies and new pharmacological developments via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979 via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone via openalex
- Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells via openalex
- Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
Source provenance
- openalex
- last seen: 2026-05-11T08:53:43.914613+00:00
License: CC0
· commercial use OK